Festdosierte Kombinationszusammensetzung aus Metformin und Empagliflozin

Details

Veröffentlichungs-Nr.

EP4403168

Aktenzeichen

EP23152206

Anmeldetag

18. Januar 2023

Veröffentlichung

24. Juli 2024

Rechtsraum

EP

IPC

A61K9/24A61K31/155A61K31/7048A61P3/10

Abstract

A fixed-dose pharmaceutical preparation in the form of a coated tablet for oral administration comprising extended release metformin hydrochloride as the core of the tablet, coated with an intermediate coating based on hydroxypropylmethylcellulose as a film-forming material, further coated with empagliflozin comprising active coating based on partially hydrolyzed polyvinyl alcohol as a film-forming material, and further optionally coated with outer protective coating.

Anmelder

Firma

Adamed Pharma S.A.

Land

🇵🇱 Polen

Fachgebiete